成人2型糖尿病治疗进展。

BMJ medicine Pub Date : 2023-09-04 eCollection Date: 2023-01-01 DOI:10.1136/bmjmed-2022-000372
Rodolfo J Galindo, Jennifer M Trujillo, Cecilia C Low Wang, Rozalina G McCoy
{"title":"成人2型糖尿病治疗进展。","authors":"Rodolfo J Galindo, Jennifer M Trujillo, Cecilia C Low Wang, Rozalina G McCoy","doi":"10.1136/bmjmed-2022-000372","DOIUrl":null,"url":null,"abstract":"<p><p>Type 2 diabetes is a chronic and progressive cardiometabolic disorder that affects more than 10% of adults worldwide and is a major cause of morbidity, mortality, disability, and high costs. Over the past decade, the pattern of management of diabetes has shifted from a predominantly glucose centric approach, focused on lowering levels of haemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>), to a directed complications centric approach, aimed at preventing short term and long term complications of diabetes, and a pathogenesis centric approach, which looks at the underlying metabolic dysfunction of excess adiposity that both causes and complicates the management of diabetes. In this review, we discuss the latest advances in patient centred care for type 2 diabetes, focusing on drug and non-drug approaches to reducing the risks of complications of diabetes in adults. We also discuss the effects of social determinants of health on the management of diabetes, particularly as they affect the treatment of hyperglycaemia in type 2 diabetes.</p>","PeriodicalId":72433,"journal":{"name":"BMJ medicine","volume":"2 1","pages":"e000372"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/3c/bmjmed-2022-000372.PMC10481754.pdf","citationCount":"0","resultStr":"{\"title\":\"Advances in the management of type 2 diabetes in adults.\",\"authors\":\"Rodolfo J Galindo, Jennifer M Trujillo, Cecilia C Low Wang, Rozalina G McCoy\",\"doi\":\"10.1136/bmjmed-2022-000372\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Type 2 diabetes is a chronic and progressive cardiometabolic disorder that affects more than 10% of adults worldwide and is a major cause of morbidity, mortality, disability, and high costs. Over the past decade, the pattern of management of diabetes has shifted from a predominantly glucose centric approach, focused on lowering levels of haemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>), to a directed complications centric approach, aimed at preventing short term and long term complications of diabetes, and a pathogenesis centric approach, which looks at the underlying metabolic dysfunction of excess adiposity that both causes and complicates the management of diabetes. In this review, we discuss the latest advances in patient centred care for type 2 diabetes, focusing on drug and non-drug approaches to reducing the risks of complications of diabetes in adults. We also discuss the effects of social determinants of health on the management of diabetes, particularly as they affect the treatment of hyperglycaemia in type 2 diabetes.</p>\",\"PeriodicalId\":72433,\"journal\":{\"name\":\"BMJ medicine\",\"volume\":\"2 1\",\"pages\":\"e000372\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/3c/bmjmed-2022-000372.PMC10481754.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjmed-2022-000372\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjmed-2022-000372","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2型糖尿病是一种慢性进行性心脏代谢紊乱,影响着全球超过10%的成年人,是发病率、死亡率、残疾和高成本的主要原因。在过去的十年里,糖尿病的管理模式已经从主要以葡萄糖为中心的方法转变为以降低血红蛋白A1c(HbA1c)水平为重点的方法,转变为以并发症为中心的直接方法,旨在预防糖尿病的短期和长期并发症,它着眼于过度肥胖的潜在代谢功能障碍,这既导致糖尿病的治疗,又使糖尿病的治疗复杂化。在这篇综述中,我们讨论了以患者为中心的2型糖尿病护理的最新进展,重点是降低成人糖尿病并发症风险的药物和非药物方法。我们还讨论了健康的社会决定因素对糖尿病管理的影响,特别是当它们影响2型糖尿病高血糖的治疗时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Advances in the management of type 2 diabetes in adults.

Type 2 diabetes is a chronic and progressive cardiometabolic disorder that affects more than 10% of adults worldwide and is a major cause of morbidity, mortality, disability, and high costs. Over the past decade, the pattern of management of diabetes has shifted from a predominantly glucose centric approach, focused on lowering levels of haemoglobin A1c (HbA1c), to a directed complications centric approach, aimed at preventing short term and long term complications of diabetes, and a pathogenesis centric approach, which looks at the underlying metabolic dysfunction of excess adiposity that both causes and complicates the management of diabetes. In this review, we discuss the latest advances in patient centred care for type 2 diabetes, focusing on drug and non-drug approaches to reducing the risks of complications of diabetes in adults. We also discuss the effects of social determinants of health on the management of diabetes, particularly as they affect the treatment of hyperglycaemia in type 2 diabetes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Long covid as a long term condition. Blood level of neurofilament light chain as a biomarker for neurological disorders. Vaccine effectiveness against mild and severe covid-19 in pregnant individuals and their infants in England: test negative case-control study. Caesarean section and risk of infection in offspring: systematic review and meta-analysis of observational studies. Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1